Menaderm Simple (Beclometasone Dipropionate)

The active ingredient binds to glucocorticoid receptors in skin cells, altering gene transcription to suppress inflammatory cytokines, reduce leukocyte migration, and limit vascular permeability, thereby providing anti‑inflammatory and immunosuppressive effects at the site of application.

The appropriate dose and frequency are determined by the prescribing clinician based on the severity of the skin condition, the area to be treated and patient-specific factors. Patients should follow the exact instructions provided on the prescription label.

Safety data for beclometasone dipropionate in pregnancy and lactation are limited. It should only be used if the potential benefit justifies any possible risk to the fetus or infant, and this decision must be made by a qualified healthcare professional.

To place an order, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Beclometasone dipropionate is a medium‑potency corticosteroid, offering a balance between efficacy and safety. Compared with lower‑potency agents it provides stronger anti‑inflammatory action, while higher‑potency steroids may carry a greater risk of skin atrophy and systemic absorption.

Store Menaderm Simple at room temperature, preferably below 25 °C. Keep the product in its original packaging, protect it from moisture and direct sunlight, and ensure the container is tightly closed when not in use.

The cream should be applied thinly to the affected skin area once or twice daily, as directed by the prescriber. Gently massage until fully absorbed, avoiding contact with eyes, mouth and open wounds unless specifically instructed.

Serious risks include skin atrophy, development of stretch marks, hypopigmentation and, with extensive use, possible systemic absorption leading to adrenal suppression. Patients should report any unusual skin changes or systemic symptoms to their healthcare provider promptly.

Menaderm Simple should not be used by individuals with known hypersensitivity to beclometasone dipropionate or any excipients in the formulation, nor on skin that is infected, ulcerated, or compromised without prior medical evaluation.